One Foot In The Door? Trio Look To Reenter Annulled EU Generic Tecfidera Market

Positive CHMP Recommendations Follow Biogen Winning February 2025 Exclusivity

A topsy-turvy legal battle going back some years led to a raft of Tecfidera generics being pulled from the market in December last year. Now, three of the affected companies are a step closer to reentering the market, which is set to remain a Tecfidera monopoly until February 2025.

A young man' hand is displaying a thumbs up, indicating that he likes or approves of something - Image
• Source: Shutterstock

More from Generics

More from Products